147 related articles for article (PubMed ID: 24103199)
41. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
42. Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
Nagill R; Kaur S
Vaccine; 2010 May; 28(23):4002-12. PubMed ID: 20093205
[TBL] [Abstract][Full Text] [Related]
43. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
Paila YD; Saha B; Chattopadhyay A
Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
[TBL] [Abstract][Full Text] [Related]
44. Antileishmanial effect of free and encapsulated sinefungin against Leishmania donovani infections in BALB/c mice.
Neal RA; Iwobi MV; Robert-Gero M
C R Acad Sci III; 1989; 308(18):485-8. PubMed ID: 2508995
[TBL] [Abstract][Full Text] [Related]
45. Leishmanicidal activity assessment of olive tree extracts.
Kyriazis JD; Aligiannis N; Polychronopoulos P; Skaltsounis AL; Dotsika E
Phytomedicine; 2013 Feb; 20(3-4):275-81. PubMed ID: 23273752
[TBL] [Abstract][Full Text] [Related]
46. Successful Therapy of Murine Visceral Leishmaniasis with Astrakurkurone, a Triterpene Isolated from the Mushroom Astraeus hygrometricus, Involves the Induction of Protective Cell-Mediated Immunity and TLR9.
Mallick S; Dutta A; Chaudhuri A; Mukherjee D; Dey S; Halder S; Ghosh J; Mukherjee D; Sultana SS; Biswas G; Lai TK; Patra P; Sarkar I; Chakraborty S; Saha B; Acharya K; Pal C
Antimicrob Agents Chemother; 2016 May; 60(5):2696-708. PubMed ID: 26883702
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of antileishmanial efficacy of Salidroside against the SSG-sensitive and resistant strain of Leishmania donovani.
Chauhan K; Kaur G; Kaur S
Parasitol Int; 2019 Oct; 72():101928. PubMed ID: 31108221
[TBL] [Abstract][Full Text] [Related]
48. Leishmania donovani Impedes Antileishmanial Immunity by Suppressing Dendritic Cells via the TIM-3 Receptor.
Akhtar MN; Kumar S; Sen P
mBio; 2022 Aug; 13(4):e0330921. PubMed ID: 35924848
[TBL] [Abstract][Full Text] [Related]
49. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B
J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711
[TBL] [Abstract][Full Text] [Related]
50. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
51. Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis.
de Jesus JA; Laurenti MD; Antonangelo L; Faria CS; Lago JHG; Passero LFD
J Immunol Res; 2021; 2021():6671287. PubMed ID: 33681389
[TBL] [Abstract][Full Text] [Related]
52. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
53. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
Melby PC; Yang J; Zhao W; Perez LE; Cheng J
Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
[TBL] [Abstract][Full Text] [Related]
54. Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis.
Nagill R; Mahajan R; Sharma M; Kaur S
Parasitol Int; 2009 Dec; 58(4):359-66. PubMed ID: 19638322
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of In vitro and In vivo Protective Efficacy of Bauhinia variegata Against Leishmania donovani in Murine Model.
Kaur G; Chauhan K; Anand N; Kaur S
Acta Parasitol; 2021 Sep; 66(3):812-826. PubMed ID: 33528770
[TBL] [Abstract][Full Text] [Related]
56. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
Tavares GSV; Mendonça DVC; Miyazaki CK; Lage DP; Soyer TG; Carvalho LM; Ottoni FM; Dias DS; Ribeiro PAF; Antinarelli LMR; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
Parasitol Int; 2019 Feb; 68(1):63-72. PubMed ID: 30339837
[TBL] [Abstract][Full Text] [Related]
57. Protective therapy with novel chromone derivative against Leishmania donovani infection induces Th1 response in vivo.
Mallick S; Dutta A; Ghosh J; Maiti S; Mandal AK; Banerjee R; Bandyopadhyay C; Pal C
Chemotherapy; 2011; 57(5):388-93. PubMed ID: 22024637
[TBL] [Abstract][Full Text] [Related]
58. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
59. Curative efficacy of purified serine protease inhibitor PTF3 from potato tuber in experimental visceral leishmaniasis.
Paik D; Pramanik PK; Chakraborti T
Int Immunopharmacol; 2020 Aug; 85():106623. PubMed ID: 32504996
[TBL] [Abstract][Full Text] [Related]
60. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
Everlien H; Hockertz S
Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
